Leibowitz backs Obama plan to end pay-for-delay settlements
Tuesday, 20 September 2011
Ron Knox
The chairman of the US Federal Trade Commission has pledged support for a component of President Barack Obama’s deficit reduction plan that would make it harder for branded drug companies to settle patent litigation by paying their generic rivals.
Subscription required to view this article
This content can only be accessed by GCR subscribers.
A subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current print and online content.
Please note: If you would like online access to all archived content, you will need a Premium subscription.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top